Medkart Pharmacy is an Indian-based startup founded in 2014, operating in the health care and pharmaceutical industries. The company's mission is reflected in its slogan "Quality Ki Surety" and its dedication to providing WHO-GMP certified generic medicines. Medkart aims to address the issue of affordability in the pharmaceutical industry, believing that medicines are inherently affordable but have been systematically made expensive. The company emphasizes raising awareness about generic medicines and advocating for patients' right to choose their preferred brand of medication, similar to how they choose other consumer products. This approach is common in developed countries, and Medkart seeks to empower patients with the necessary information to make informed decisions in India.
The latest milestone for Medkart Pharmacy was a significant Series A investment of INR400.00M from a group of investors including Insitor Impact Asia Fund, Alkemi Growth Capital, and Prashant Poddar, which was secured on 23 November 2021. This investment not only reflects confidence in Medkart's vision but also provides the necessary resources for the company to further its mission of making patients aware of the benefits of generic medicines and facilitating informed choices in the Indian market.
No recent news or press coverage available for Medkart Pharmacy.